Immunologic mechanism for human immunodeficiency virus type 1 gp120 vaccine failure [5]

Journal of Infectious Diseases

Volumn 173, Issue 2, 1996, Pages 512-513

  O'Toole, C ^a   Muller, S ^a   Nara, P ^a   Kohler, H ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACTIVE IMMUNIZATION; ADULT; ANIMAL EXPERIMENT; CASE REPORT; CHIMPANZEE; DRUG FORMULATION; DRUG MONITORING; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; MALE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT FAILURE;

EID: 0030053424     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.2.512     Document Type: Letter

References (0)